ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 5, 2010, Pages 819-828

  Shi, Jianjian ^a   Zhang, Yi Wei ^a   Yang, Yu ^a   Zhang, Lumin ^a   Wei, Lei ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Apoptosis; Bax; ERK MAPK; G q; Heart failure; Rho kinase; ROCK1

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAX; RHO ASSOCIATED COILED COIL CONTAINING PROTEIN KINASE 1; RHO KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; ENZYME DEFICIENCY; ENZYME INHIBITION; GENE DELETION; GENE OVEREXPRESSION; GENE TRANSLOCATION; HEART CONTRACTION; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE DILATATION; HEART LEFT VENTRICLE WALL; HEART MUSCLE CELL; MITOCHONDRION; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PERIPARTUM MORTALITY; PRIORITY JOURNAL; UPREGULATION;

AGING; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARDIOMEGALY; DISEASE PROGRESSION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE DELETION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEART FAILURE; HEART FUNCTION TESTS; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; RHO-ASSOCIATED KINASES; UP-REGULATION;

MUS; MUS MUSCULUS;

EID: 77957236340     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.08.008     Document Type: Article

References (30)

1. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev 2006, 7:589-600.
2. Brown J.H., Del Re D.P., Sussman M.A. The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ Res 2006, 98:730-742.
3. Hill J.A., Olson E.N. Cardiac plasticity. N Engl J Med 2008, 358:1370-1380.
4. Shi J., Wei L. Rho kinase in the regulation of cell death and survival. Arch Immunol Ther Exp (Warsz) 2007, 55:61-75.
5. Loirand G., Guerin P., Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 2006, 98:322-334.
6. Noma K., Oyama N., Liao J.K. Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol 2006, 290:C661-C668.
7. Satoh S., Ueda Y., Koyanagi M., Kadokami T., Sugano M., Yoshikawa Y., et al. Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure. J Mol Cell Cardiol 2003, 35:59-70.
8. Higashi M., Shimokawa H., Hattori T., Hiroki J., Mukai Y., Morikawa K., et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 2003, 93:767-775.
9. Hattori T., Shimokawa H., Higashi M., Hiroki J., Mukai Y., Tsutsui H., et al. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation 2004, 109:2234-2239.
10. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990-994.
11. Chang J., Xie M., Shah V.R., Schneider M.D., Entman M.L., Wei L., et al. Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis. Proc Natl Acad Sci USA 2006, 103:14495-14500.
12. Zhang Y.M., Bo J., Taffet G.E., Chang J., Shi J., Reddy A.K., et al. Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. FASEB J 2006, 20:916-925.
13. Shi J., Zhang Y.W., Summers L.J., Dorn G.W., Wei L. Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy. J Mol Cell Cardiol 2008, 44:551-560.
14. Rikitake Y., Oyama N., Wang C.Y., Noma K., Satoh M., Kim H.H., et al. Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice. Circulation 2005, 112:2959-2965.
15. Adams J.W., Sakata Y., Davis M.G., Sah V.P., Wang Y., Liggett S.B., et al. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 1998, 95:10140-10145.
16. D'Angelo D.D., Sakata Y., Lorenz J.N., Boivin G.P., Walsh R.A., Liggett S.B., et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 1997, 94:8121-8126.
17. Roth D.M., Bayat H., Drumm J.D., Gao M.H., Swaney J.S., Ander A., et al. Adenylyl cyclase increases survival in cardiomyopathy. Circulation 2002, 105:1989-1994.
18. Yussman M.G., Toyokawa T., Odley A., Lynch R.A., Wu G., Colbert M.C., et al. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 2002, 8:725-730.
19. Hayakawa Y., Chandra M., Miao W., Shirani J., Brown J.H., Dorn G.W., et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 2003, 108:3036-3041.
20. Gulick J., Subramaniam A., Neumann J., Robbins J. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 1991, 266:9180-9185.
21. Wei L., Taffet G.E., Khoury D.S., Bo J., Li Y., Yatani A., et al. Disruption of Rho signaling results in progressive atrioventricular conduction defects while ventricular function remains preserved. FASEB J 2004, 18:857-859.
22. Diwan A., Wansapura J., Syed F.M., Matkovich S.J., Lorenz J.N., Dorn G.W. Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation. Circulation 2008, 117:396-404.
23. Howes A.L., Arthur J.F., Zhang T., Miyamoto S., Adams J.W., Dorn I.G., et al. Akt-mediated cardiomyocyte survival pathways are compromised by G alpha q-induced phosphoinositide 4, 5-bisphosphate depletion. J Biol Chem 2003, 278:40343-40351.
24. Dorn G.W., Tepe N.M., Wu G., Yatani A., Liggett S.B. Mechanisms of impaired beta-adrenergic receptor signaling in G(alphaq)-mediated cardiac hypertrophy and ventricular dysfunction. Mol Pharmacol 2000, 57:278-287.
25. Lorenz K., Schmitt J.P., Vidal M., Lohse M.J. Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling. Int J Biochem Cell Biol 2009, 41:2351-2355.
26. Purcell N.H., Wilkins B.J., York A., Saba-El-Leil M.K., Meloche S., Robbins J., et al. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc Natl Acad Sci USA 2007, 104:14074-14079.
27. Baines C.P., Molkentin J.D. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 2005, 38:47-62.
28. Del Re D.P., Miyamoto S., Brown J.H. RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J Biol Chem 2007, 282:8069-8078.
29. Bleicken S., Zeth K. Conformational changes and protein stability of the pro-apoptotic protein Bax. J Bioenerg Biomembr 2009, 41:29-40.
30. Olson M.F. Applications for ROCK kinase inhibition. Curr Opin Cell Biol 2008, 20:242-248.